Claro Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Claro Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$9K	–	334
2022 Q1	$9K	Hold	3	–	–	﹤0.01%	282
2021 Q4	$9K	Buy	+3	New	+$10.4K	﹤0.01%	282

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Claro Advisors's TTOO Position: Q2 2022 in Review

Claro Advisors sold out of T2 Biosystems, Inc (TTOO) in Q2 2022, closing a stake of 3 shares — an estimated $9K sold.

Claro Advisors first reported a position in TTOO in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q1 2022. 58 funds tracked by Wall St. Rank hold TTOO as of Q2 2022.

Claro Advisors reported no remaining T2 Biosystems, Inc position as of Q2 2022 after selling out during the quarter.
Claro Advisors sold 3 T2 Biosystems, Inc shares in Q2 2022, an estimated $9K.
Claro Advisors first reported a position in T2 Biosystems, Inc in Q4 2021 and held it in 2 quarters.
Claro Advisors's T2 Biosystems, Inc position peaked at $9K in Q1 2022.
58 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2022.

Based on Claro Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.